Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · IEX Real-Time Price · USD
6.15
-0.38 (-5.82%)
At close: May 17, 2024, 4:00 PM
6.10
-0.05 (-0.81%)
After-hours: May 17, 2024, 7:28 PM EDT

Nuvectis Pharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020
Selling, General & Admin
7.526.013.350.01
Research & Development
15.3813.239.550
Operating Expenses
22.919.2312.890.01
Operating Income
-22.9-19.23-12.89-0.01
Other Expense / Income
-0.64-0.15-0-
Pretax Income
-22.26-19.09-12.89-0.01
Net Income
-22.26-19.09-12.89-0.01
Shares Outstanding (Basic)
161340
Shares Outstanding (Diluted)
161340
Shares Change
22.90%196.55%4168.28%-
EPS (Basic)
-1.43-1.51-3.02-0.10
EPS (Diluted)
-1.43-1.51-3.02-0.10
Free Cash Flow
-15.95-13.56-9.50
Free Cash Flow Per Share
-1.03-1.07-2.23-
EBITDA
-22.26-19.09-12.89-0.01
EBIT
-22.26-19.09-12.89-0.01
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).